Corning To Get $204 Million From BARDA To Boost Vial Capacity for Coronavirus Needs

Reuters  |

Image source: Corning

(Reuters) - Glass maker Corning Inc said on Tuesday it would receive $204 million from the U.S. government to boost the manufacturing capacity of its vials that will be used to store coronavirus vaccines and treatments.

Companies developing coronavirus vaccines, such as AstraZeneca and Johnson & Johnson, have flagged potential supply shortages of glass vials, which could pose a challenge to scaling up the production of a vaccine.

Trade Commission-FREE with Tradier Brokerage

Billions of vials will be needed for vaccines of the new coronavirus, with world leaders looking towards treatments as a way to re-open stalled economies.

Corning will provide priority access of its vials to companies that have tied up with the Biomedical Advanced Research and Development Authority (BARDA) for developing treatments and vaccines.

The funding from BARDA will go towards scaling up production of the company’s ‘Valor Glass’, which is designed to minimize contamination and could potentially speed up manufacturing processes.

The company signed a long-term agreement in May with Pfizer Inc, which is also developing a coronavirus vaccine, for the glass vials. Pfizer said they would be used for some existing sterile injectable drugs and a range of new products.

Reporting by Manas Mishra and Saumya Sibi Joseph in Bengaluru; Editing by Krishna Chandra Eluri.

_____

Source: Reuters

Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     
BA

     
WMT

     
DIS

     
GOOG

     
XOM

     
BRK.A

     
FB

     
JNJ

     
WFC

     
T

     
NFLX

     
TSLA

     
V

     
UNH

     
PG

     

Markets